Selected research
Industry Research
Pharmaceutical Impurity Analysis Service Industry Research Report 2026
Market perspective
The global Pharmaceutical Impurity Analysis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Impurity Analysis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Impurity Analysis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Impurity Analysis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Impurity Analysis Service include Intertek, Creative Proteomics, Emery Pharma, Agilent, Vimta, Alfa Chemistry, Eurofins, Alera Labs and Impact Analytical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Impurity Analysis Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Impurity Analysis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Impurity Analysis Service Market by Company
Intertek
Creative Proteomics
Emery Pharma
Agilent
Vimta
Alfa Chemistry
Eurofins
Alera Labs
Impact Analytical
Leeder Analytical
Nelson Labs
Reading Scientific Services
Regis Technologies
Selvita
SGS
Pharmaceutical Impurity Analysis Service Segment by Type
Organic Impurity Analysis
Inorganic Impurity Analysis
Residual Solvent Analysis
Others
Pharmaceutical Impurity Analysis Service Segment by Application
Pharmaceutical Industry
Agriculture
Biotechnology
Others
Pharmaceutical Impurity Analysis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Impurity Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Impurity Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Impurity Analysis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Impurity Analysis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Organic Impurity Analysis
- Inorganic Impurity Analysis
- Residual Solvent Analysis
- Others
Applications
- Pharmaceutical Industry
- Agriculture
- Biotechnology
- Others
Companies covered
- Intertek
- Creative Proteomics
- Emery Pharma
- Agilent
- Vimta
- Alfa Chemistry
- Eurofins
- Alera Labs
- Impact Analytical
- Leeder Analytical
- Nelson Labs
- Reading Scientific Services
- Regis Technologies
- Selvita
- SGS
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Impurity Analysis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Organic Impurity Analysis
- 2.2.3 Inorganic Impurity Analysis
- 2.2.4 Residual Solvent Analysis
- 2.2.5 Others
- 2.3 Pharmaceutical Impurity Analysis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Agriculture
- 2.3.4 Biotechnology
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Pharmaceutical Impurity Analysis Service Breakdown Data by Type
- 3.1 Global Pharmaceutical Impurity Analysis Service Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Impurity Analysis Service Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Impurity Analysis Service Breakdown Data by Application
- 4.1 Global Pharmaceutical Impurity Analysis Service Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Impurity Analysis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Impurity Analysis Service Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Impurity Analysis Service Growth Trends by Region
- 5.2.1 Global Pharmaceutical Impurity Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Impurity Analysis Service Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Impurity Analysis Service Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Impurity Analysis Service Market Dynamics
- 5.3.1 Pharmaceutical Impurity Analysis Service Industry Trends
- 5.3.2 Pharmaceutical Impurity Analysis Service Market Drivers
- 5.3.3 Pharmaceutical Impurity Analysis Service Market Challenges
- 5.3.4 Pharmaceutical Impurity Analysis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Impurity Analysis Service Players by Revenue
- 6.1.1 Global Top Pharmaceutical Impurity Analysis Service Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Impurity Analysis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Impurity Analysis Service Head Office and Area Served
- 6.4 Global Pharmaceutical Impurity Analysis Service Players, Product Type & Application
- 6.5 Global Pharmaceutical Impurity Analysis Service Manufacturers Established Date
- 6.6 Global Pharmaceutical Impurity Analysis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
- 7.2 North America Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
- 10.2 South America Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Intertek
- 12.1.1 Intertek Company Information
- 12.1.2 Intertek Business Overview
- 12.1.3 Intertek Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.1.4 Intertek Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.1.5 Intertek Recent Developments
- 12.2 Creative Proteomics
- 12.2.1 Creative Proteomics Company Information
- 12.2.2 Creative Proteomics Business Overview
- 12.2.3 Creative Proteomics Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.2.4 Creative Proteomics Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.2.5 Creative Proteomics Recent Developments
- 12.3 Emery Pharma
- 12.3.1 Emery Pharma Company Information
- 12.3.2 Emery Pharma Business Overview
- 12.3.3 Emery Pharma Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.3.4 Emery Pharma Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.3.5 Emery Pharma Recent Developments
- 12.4 Agilent
- 12.4.1 Agilent Company Information
- 12.4.2 Agilent Business Overview
- 12.4.3 Agilent Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.4.4 Agilent Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.4.5 Agilent Recent Developments
- 12.5 Vimta
- 12.5.1 Vimta Company Information
- 12.5.2 Vimta Business Overview
- 12.5.3 Vimta Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.5.4 Vimta Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.5.5 Vimta Recent Developments
- 12.6 Alfa Chemistry
- 12.6.1 Alfa Chemistry Company Information
- 12.6.2 Alfa Chemistry Business Overview
- 12.6.3 Alfa Chemistry Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.6.4 Alfa Chemistry Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.6.5 Alfa Chemistry Recent Developments
- 12.7 Eurofins
- 12.7.1 Eurofins Company Information
- 12.7.2 Eurofins Business Overview
- 12.7.3 Eurofins Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.7.4 Eurofins Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.7.5 Eurofins Recent Developments
- 12.8 Alera Labs
- 12.8.1 Alera Labs Company Information
- 12.8.2 Alera Labs Business Overview
- 12.8.3 Alera Labs Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.8.4 Alera Labs Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.8.5 Alera Labs Recent Developments
- 12.9 Impact Analytical
- 12.9.1 Impact Analytical Company Information
- 12.9.2 Impact Analytical Business Overview
- 12.9.3 Impact Analytical Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.9.4 Impact Analytical Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.9.5 Impact Analytical Recent Developments
- 12.10 Leeder Analytical
- 12.10.1 Leeder Analytical Company Information
- 12.10.2 Leeder Analytical Business Overview
- 12.10.3 Leeder Analytical Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.10.4 Leeder Analytical Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.10.5 Leeder Analytical Recent Developments
- 12.11 Nelson Labs
- 12.11.1 Nelson Labs Company Information
- 12.11.2 Nelson Labs Business Overview
- 12.11.3 Nelson Labs Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.11.4 Nelson Labs Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.11.5 Nelson Labs Recent Developments
- 12.12 Reading Scientific Services
- 12.12.1 Reading Scientific Services Company Information
- 12.12.2 Reading Scientific Services Business Overview
- 12.12.3 Reading Scientific Services Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.12.4 Reading Scientific Services Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.12.5 Reading Scientific Services Recent Developments
- 12.13 Regis Technologies
- 12.13.1 Regis Technologies Company Information
- 12.13.2 Regis Technologies Business Overview
- 12.13.3 Regis Technologies Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.13.4 Regis Technologies Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.13.5 Regis Technologies Recent Developments
- 12.14 Selvita
- 12.14.1 Selvita Company Information
- 12.14.2 Selvita Business Overview
- 12.14.3 Selvita Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.14.4 Selvita Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.14.5 Selvita Recent Developments
- 12.15 SGS
- 12.15.1 SGS Company Information
- 12.15.2 SGS Business Overview
- 12.15.3 SGS Revenue in Pharmaceutical Impurity Analysis Service Business (2021-2026)
- 12.15.4 SGS Pharmaceutical Impurity Analysis Service Product Portfolio
- 12.15.5 SGS Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst